CareLit · DOI-Nachweis · Ultraschall in der Medizin - European Journal of Ultrasound
POST-MARKETING RETROSPECTIVE ANALYSIS ON THE SAFETY OF SONOVUE, A SECOND GENERATION ULTRASOUND CONTRAST AGENT, IN ABDOMINAL APPLICATIONS. REPORT FROM 23.188 PATIENTS STUDIED IN ITALY
DOI 10.1055/s-2005-917536
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Piscaglia, L Bolondi, IUMB Study Group on SonoVue Safety S
ZeitschriftUltraschall in der Medizin - European Journal of Ultrasound
Ausgabe09/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Purpose: No study have yet investigated the incidence of adverse events in the real clinical practice with Sulphur Exafluoride (SonoVue) – an ultrasound contrast agent introduced on the market in Italy at the end of 2001. Assessing such incidence was therefore the aim of the present retrospective study proposed by the Italian Society for Ultrasound in Medicine and Biology (SIUMB). Methods and Materials: A total of 2…
Zitieren
Zitierempfehlung
F Piscaglia, L Bolondi, IUMB Study Group on SonoVue Safety S (2005) POST-MARKETING RETROSPECTIVE ANALYSIS ON THE SAFETY OF SONOVUE, A SECOND GENERATION ULTRASOUND CONTRAST AGENT, IN ABDOMINAL APPLICATIONS. REPORT FROM 23.188 PATIENTS STUDIED IN ITALY. Ultraschall in der Medizin - European Journal of Ultrasound (09). https://doi.org/10.1055/s-2005-917536
Mit CareLit weiterarbeiten